Related Experiment Video
Updated: Jul 8, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Effect of hormone replacement therapy on postmenopausal endometrial bleeding
Zoltan Magyar1, Eniko Berkes, Zsolt Csapo
11st Department of Obstetrics and Gynecology, Faculty of Medicine, Semmelweis University, Budapest, Hungary. magyar@noi1.sote.hu
Pathology Oncology Research : POR
|December 26, 2007
Summary
Postmenopausal hormone replacement therapy (HRT) impacts endometrial bleeding and tissue changes. Continuous combined HRT appears to reduce hyperplasia risk, while estrogen-only therapy may increase it.
Area of Science:
- Gynecology
- Endocrinology
- Reproductive Medicine
Background:
- Postmenopausal hormone replacement therapy (HRT) is used to manage menopausal symptoms.
- Understanding HRT's effects on the endometrium is crucial for patient safety.
- Endometrial bleeding and histological changes are key indicators of endometrial health.
Purpose of the Study:
- To evaluate the impact of different types of postmenopausal HRT on endometrial bleeding.
- To analyze histological changes in the endometrium associated with various HRT regimens.
- To compare endometrial outcomes between HRT users and non-users.
Main Methods:
- A retrospective study of 5893 patients over six years (2000-2005).
- Analysis of endometrial bleeding incidence in HRT and non-HRT groups.
- Histological examination of endometrial samples obtained via fractioned abrasion for bleeding cases.
Main Results:
- Postmenopausal patients not receiving HRT had a significantly higher incidence of bleeding episodes.
- Proliferative endometrium was more common in non-treated and sequential combined HRT groups compared to continuous combined HRT.
- Estrogen-only therapy was associated with a significantly higher incidence of endometrial hyperplasia.
- Continuous combined HRT showed a trend towards reduced incidence of hyperplasia simplex and complex.
- No complex hyperplasia with atypia was observed in HRT users; only hyperplasia simplex was diagnosed.
Conclusions:
- Continuous combined HRT, especially when initiated early, may decrease the risk of endometrial hyperplasia.
- Estrogen-only therapy might exacerbate existing endometrial hyperplasia.
- Atrophic endometrium in continuous combined HRT users reduces hyperplasia-related changes and bleeding.
- HRT, particularly continuous combined preparations, does not appear to increase the risk of endometrial carcinoma and may reduce hyperplasia risk.
Related Concept Videos
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:19The Menstrual Cycle
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
01:18Menses Phase
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:20Proliferative Phase
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...